Catalyst Wire Dossier Catalyst Wire Dossier

subcutaneous basal insulin

basal insulin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for subcutaneous basal insulin, covering 2022-03-10 to 2022-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Concurrent Subcutaneous Basal Insulin and Intravenous Insulin Pump in Hyperglycemic Crisis Patients Under Critical Care [Phase 2]

See pricing